Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000131

Director sold 797 shares at $21.17 ($16,872)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Greenleaf Peter · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-10-02 Sale : show line 1 in the form 10b5-1 −797 $21.17 $16,872 23,087 D
Open-market sales · 797 sh · avg $21.17 · $16,872
Loading xslF345X06/wk-form4_1791323650.xml…